Greatview Aseptic Packaging (HKG:0468) said a second-stage independent investigation has found evidence of serious irregularities involving certain former members of management, according to a Thursday Hong Kong bourse filing.
The company said the probe raised concerns over the accuracy and completeness of disclosures tied to a restructuring announced in January 2024, including whether the group retained control of its international business.
Investigators found evidence suggesting customer complaints cited to justify the restructuring may not have originated independently from overseas customers.
The report flagged undisclosed management involvement in fund and trust structures linked to the restructuring, as well as one-sided commercial contracts that disadvantaged the group.
It also identified evidence indicating that transaction size ratios were adjusted in a manner that kept the deal below the 25% threshold under Hong Kong listing rules.
Investigators said the restructuring should likely have been classified as a major transaction and may have required shareholder approval.
The report also noted that the group has not received any distributions from the investment fund formed as part of the restructuring.
The investigation identified improperly authorized loans, questionable expense payments, and potential undisclosed related-party transactions.
It also found that staff, systems, equipment, and business resources were transferred to a separately operated entity, weakening the group's international operations.
Greatview said the special investigation committee has recommended reporting the matter to enforcement authorities and pursuing legal action against relevant former management, counterparties, and potentially professional advisers.
Trading in the company's shares has been suspended since Feb. 19, 2025, and will remain suspended until further notice.
Comments